IL6 and rheumatoid arthritis: Effects of bDMARDs including TNF inhibitors [16, 17] and IL-6 inhibitors [18–20] on bone biomarkers in patients with RA have been reported, but the effect of abatacept on bone biomarkers in patients with RA has not been investigated.